Trials / Unknown
UnknownNCT00893490
Ahmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma
Ahmed Glaucoma Valve Alone,With Amniotic Membrane or With MMC for Treatment of Refractory Glaucoma
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Shahid Beheshti University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 7 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This randomized, controlled trial (RCT) compares the efficacy and safety of Ahmed Glaucoma Valve (AGV) implantation alone, with 3 minutes MMC application or with a single layer coverage of amniotic membrane. Outcomes include intraocular eye pressure (IOP), postoperative glaucoma medication and complications. AGV implantation site will be superior or inferior based on indication and these groups will be randomized separately.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ahmed Glaucoma Valve (AGV) | AGV implantation |
| DRUG | Mitomycin C (MMC) | 3 minute MMC application |
| PROCEDURE | amniotic membrane coverage | single layer coverage of amniotic membrane |
Timeline
- First posted
- 2009-05-06
- Last updated
- 2009-05-06
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00893490. Inclusion in this directory is not an endorsement.